“alzheimers”的搜索结果，显示 61-70 项，共有 5576 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants.

2. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants.

3. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) ... Clinical/cognitive, imaging, biomarker, and genetic characteristics will be ...

4. 轻度认知损害- 症状与病因- 妙佑医疗国际

   Alzheimer's Association. https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment. Accessed Sept. 21, 2022 ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) ... Clinical/cognitive, imaging, biomarker, and genetic characteristics will be ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants.

7. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants.

9. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) ... Clinical/cognitive, imaging, biomarker, and genetic characteristics will be ...

10. 神经科- 临床试验- 妙佑医疗国际

    Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...